Research
Molecular
GLP-1 receptor agonist patients had significantly lower serum albumin (4.06 g/dL) and prealbumin levels (23.52 mg/dL) compared to controls (4.22 g/dL and 25.55 mg/dL, respectively).
Monitoring nutritional status, including serum albumin and prealbumin, may be important for patients on GLP-1 receptor agonists.
StrongSupportsmedium confidence
GLP-1 patients had significantly lower serum albumin (4.06 ± 0.22 vs. 4.22 ± 0.17 g/dL, p=0.003) and prealbumin levels (23.52 ± 3.39 vs. 25.55 ± 3.10 mg/dL, p=0.02).
Why this rating
Based on a retrospective comparative case series design.
Source
Breast implant explantation with mastopexy in patients using GLP-1 receptor agonizts: A retrospective comparative analysis
Or Friedman et al. · Journal of Plastic Reconstructive & Aesthetic Surgery · 2025
other · n=60Cited 5×
Read the paper This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →